Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antiretroviral therapy
|
| gptkbp:administeredBy |
oral route
|
| gptkbp:approvedBy |
gptkb:FDA
1987 |
| gptkbp:category |
nucleoside analogues
nucleotide analogues |
| gptkbp:combines |
PI
INSTI NNRTI |
| gptkbp:drugClass |
antiviral drugs
|
| gptkbp:example |
gptkb:abacavir
gptkb:lamivudine gptkb:zidovudine emtricitabine tenofovir |
| gptkbp:hasApprovedDrug |
gptkb:zidovudine
|
| https://www.w3.org/2000/01/rdf-schema#label |
NRTI
|
| gptkbp:mechanismOfAction |
inhibits reverse transcriptase
|
| gptkbp:sideEffect |
gptkb:anemia
peripheral neuropathy lactic acidosis hepatic steatosis |
| gptkbp:standsFor |
Nucleoside Reverse Transcriptase Inhibitor
|
| gptkbp:target |
gptkb:HIV-1
gptkb:HIV-2 |
| gptkbp:usedFor |
HIV treatment
|
| gptkbp:bfsParent |
gptkb:zalcitabine
|
| gptkbp:bfsLayer |
6
|